Please provide your email address to receive an email when new articles are posted on . Percentages of patients who experienced breakthrough reactions decreased from 70% to 52% and then 43%.
A digital intervention to enhance engagement with oral oncolytic treatments and assess patient experiences with novel therapies. Severity distribution of initial HSRs and BTRs.
Racial and gender disparities in the prevalence of severe ARDS among lung cancer patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results